«Our findings suggest that different prostaglandins have different roles in antiviral immunity and that specific inhibition of PGE2 will be an effective
therapy against influenza viral infection by boosting immune responses.»
Not exact matches
«Given these results in cells and mice, it may be worthwhile to consider that patients receiving, or who may receive, Amphotericin B - based
therapies be appropriately vaccinated
against influenza virus.
In April 2017, Moderna published human data for its mRNA vaccine technology in Molecular
Therapy, which showed that its first prophylactic vaccine candidate, mRNA - 1440 — an mRNA prophylactic vaccine
against avian H10N8
influenza — induced high levels of immunogenicity and was safe and well tolerated.